Cancer
-
Sun Pharma, Philogen in agreement to commercialise NIDLEGY in Europe, Australia, New Zealand
Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for the…
Read More » -
CDSCO gives nod to Rakuten Medical to start phase 3 trial for cancer drug
The multi-centre, randomised, open-label, global Phase 3 study of Alluminox treatment using ASP-1929 will evaluate the efficacy and safety of…
Read More » -
Unipath Specialty Laboratory unveils HRD Gene Panel using SOPHiA GENETICS’ solution
The SOPHiA DDM HRD Solution will enable Unipath Specialty Laboratory to retain full ownership of their data, saving time and…
Read More » -
CAPED, Roche Diagnostics India launch cervical cancer screening prog
The partnership is part of Roche Diagnostics India #BeYourOwnShero campaign aimed at Cervical Cancer awareness and screening Roche Diagnostics India…
Read More » -
Universities of Birmingham and Leeds, FOxTROT-Global come together for cancer care initiative
Twelve hospitals across India including Tata Memorial Hospital Mumbai, and Tata Medical Centre Kolkata have proposed to be part of…
Read More » -
Delhi State Cancer Institute in MoU with Merck Specialities
The strategic collaboration will help to drive awareness, early diagnosis and counselling support to patients and family Delhi State Cancer…
Read More » -
CHL Hospitals 114 collaborates with Elekta
Unveils radiotherapy technology for precision cancer care CHL Hospitals 114, Indore, in collaboration with Elekta Medical Systems India, has launched…
Read More » -
Wockhardt Hospitals, Nashik starts oncology department
The hospital has joined hands with Nashik Oncology Group Wockhardt Hospitals, Nashik in association with Nashik Oncology Group has set…
Read More »